Archives
Elon Musk Escalates Feud With Peter Navarro as Tesla Shares Dive for Fourth Day
Elon Musk slams Peter Navarro amid Tesla stock slump, deepening feud over trade and tariffs.
Trump's TikTok Decision May Keep ByteDance in Control, Violating Law, Senator Says
Senator Mark Warner warns that Trump's extension for ByteDance to divest TikTok's U.S. assets may violate the 2024 law and jeopardize national security.
US Steel Takeover by Nippon Back in Spotlight as Trump Demands Review
Trump orders a new review of Nippon Steel's $14.9 billion acquisition of U.S. Steel after Biden blocked the deal over national security concerns.
US Tech Sector Unknowingly Funding North Korea's Weapons Program Through Fake Hires: Report
US tech companies are unknowingly funding North Korea's weapons program through a scam involving fake hires posing as American engineers.
Latest News
President Trump defends his global tariffs as necessary to fix trade imbalances, despite market turmoil and fears of a potential recession.
Trump revokes all South Sudanese visas, citing refusal to accept deported citizens, amid rising instability.
China retaliates with 34% tariffs on U.S. goods in response to President Trump's recent tariff moves, escalating the trade war between the two nations.
Jaguar Land Rover halts US shipments in response to new 25% tariffs, as the British auto industry faces growing challenges.
Elon Musk advocates for a zero-tariff trade zone between the U.S. and Europe, promoting greater economic cooperation and worker mobility.
Trump's new tariffs spark global concern as experts warn of rising costs, disrupted supply chains, and a brewing trade clash with China.
Calvin Darden Jr. sentenced to over 12 years for scamming NBA stars Dwight Howard and Chandler Parsons out of millions.
Hailey Bieber explores selling her beauty brand Rhode, valued at over $1 billion.
The Supreme Court upholds the FDA's ban on flavored vaping products, citing concerns over youth addiction and public health.
Novavax's COVID-19 vaccine faces an unexpected delay in FDA approval despite meeting all required criteria for full approval.